Deutsche Bank
NAUT icon

Deutsche Bank’s Nautilus Biotechnolgy NAUT Stock Holding History

Deutsche Bank’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.7K Buy
+48,518
New +$128K ﹤0.01% 3499
2025
Q2 		– Sell
-54,839
Closed -$47.2K – 3683
2025
Q1 		$47.2K Buy
54,839
+32,470
+145% +$48.3K ﹤0.01% 3385
2024
Q4 		$37.6K Hold
22,369
– – ﹤0.01% 3457
2024
Q3 		$63.8K Hold
22,369
– – ﹤0.01% 3313
2024
Q2 		$52.3K Hold
22,369
– – ﹤0.01% 3320
2024
Q1 		$65.8K Sell
22,369
-10,322
-32% -$29.3K ﹤0.01% 3327
2023
Q4 		$97.7K Hold
32,691
– – ﹤0.01% 3226
2023
Q3 		$103K Hold
32,691
– – ﹤0.01% 3146
2023
Q2 		$127K Sell
32,691
-8,706
-21% -$25.1K ﹤0.01% 3162
2023
Q1 		$115K Buy
41,397
+21,721
+110% +$45.6K ﹤0.01% 3271
2022
Q4 		$35.4K Buy
19,676
+318
+2% +$614 ﹤0.01% 3659
2022
Q3 		$41K Sell
19,358
-3,178
-14% -$7.99K ﹤0.01% 3643
2022
Q2 		$61K Buy
+22,536
New +$83.9K ﹤0.01% 3701

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Deutsche Bank's NAUT Position: Q2 2026 in Review

Deutsche Bank opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 48,518 shares worth $90.7K. The stake represents ﹤0.01% of the portfolio and ranks #3499 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in NAUT as recently as Q1 2025.

Deutsche Bank first reported a position in NAUT in Q2 2022 and has held it in 13 quarters since. The position peaked at $127K in Q2 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Deutsche Bank held 48,518 shares of Nautilus Biotechnolgy worth $90.7K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Deutsche Bank position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3499 holding.
  • Deutsche Bank first reported a position in Nautilus Biotechnolgy in Q2 2022 and has held it in 13 quarters since.
  • Deutsche Bank's Nautilus Biotechnolgy position peaked at $127K in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.